NasdaqCM - Nasdaq Real Time Price USD

IMAC Holdings, Inc. (BACK)

3.1000

-0.4500

(-12.68%)

At close: April 18 at 4:00 PM EDT

3.0500

-0.05

(-1.61%)

After hours: April 18 at 7:11 PM EDT

Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors

Announcement Follows Recent Public Offering and Successful Capital Raising ActivityKANSAS CITY, Kan., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, announced today that it has appointed three new directors to its board: Jay Roberts, Bryan Lawrence, and Jeff Ervin. The appointment of t

GlobeNewswire 2 months ago

BACK
-12.68%
CING
+0.69%
CINGW
Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4

Golden, Colorado & Nashville, Tennessee, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc. (OTC: THER) (“Theralink”), a precision oncology company with its exclusive commercial RPPA (reverse phase protein array) technology that can help predict which FDA-approved drug is effective in each cancer, today with its merger partner, IMAC Holdings, INC (Nasdaq: BACK), announce that the companies have responded to the SEC’s first round of comments on the jointly filed form S-4. A Form S-4 i

GlobeNewswire 5 months ago

BACK
-12.68%
THER
Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute’s Molecular Tumor Board

Golden, Colorado, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc. (OTC: THER) (“Theralink”), a precision oncology company with its exclusive commercial RPPA (reverse phase protein array) technology that can help predict which FDA-approved drug is effective in each cancer, today announced that their long-standing, strategic partnership with the Inova Schar Cancer Institute (Inova) is beginning to deliver promising results by way of assessing the feasibility and impact of the action

GlobeNewswire 5 months ago

THER

BACK
-12.68%
Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023

Golden, Colorado, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein and protein assay for breast cancer, today announces the filing of a Form S-4 with the Securities and Exchange Commission requisite to complete the previously announced merger between the Company and IMAC Holdings, Inc. (NASDAQ: BACK)(“IMAC”)(the “Merger”). Upon regulatory approval, Theralink and IMAC expect to compl

GlobeNewswire 6 months ago

BACK
-12.68%
THER
IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements

Franklin, TN, Sept. 27, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”) today announced that it has received notice from The Nasdaq Stock Market LLC informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market and that it is in compliance with all applicable listing standards. The Company’s common stock and warrants will continue to be list

GlobeNewswire 6 months ago

BACK
-12.68%
IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split

Franklin, TN, Sept. 07, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”) today announced a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-30 (the “Reverse Split”) and that it had filed a Certificate of Amendment to the Company’s Certificate of Incorporation in order to effect the Reverse Split. The Reverse Split will be effective after the market closes on September 7, 2023. Beginning with the opening of trading on September

GlobeNewswire 7 months ago

BACK
-12.68%
If You Can Only Buy One Penny Stock, It Better Be One of These 3 Names

Penny stocks are generally defined as securities that trade for less than $5 a share. These stocks can be volatile and unpredictable, leading many investors to avoid them. However, some investors with a high tolerance for risk specialize in trading penny stocks. Some have made a fortune doing so. Other investors take long-term positions in beaten-down penny stocks, buying shares on the cheap and riding them to big profits over extended periods of time. Many legendary companies have been penny st

InvestorPlace 8 months ago

TLRY

KODK

BACK
-12.68%
IMAC Holdings Announces $4.3 Million Private Placement of Convertible Preferred Stock and Warrants Priced at the Market

Franklin, Tennessee, July 26, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments, announced today that it entered into a definitive securities purchase agreement with several institutional and accredited investors, including existing significant investors of Theralink Technologies, Inc., its previously announced merger partner (OTC:THER) (“T

GlobeNewswire 8 months ago

BACK
-12.68%
IMAC Holdings Annual Meeting of Shareholders Reminder

Shareholders are reminded to vote their shares prior to the proxy voting deadline of 7:00pm on July 4, 2023 FRANKLIN, Tenn., June 28, 2023 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, reminds its shareholders that its Annual Meeting will be held July 5, 2023 at 11:00 am, local time, in Franklin, Tennessee. IMAC shareho

GlobeNewswire 9 months ago

BACK
-12.68%
Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer

Golden, Colorado, June 27, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc. (OTC: THER) ("Theralink" or the "Company"), a precision oncology company with a novel phosphoprotein and protein assay for breast cancer in the process of merging with IMAC Holdings, Inc. (NASDAQ: BACK), today announces the appointment of Faith Zaslavsky as its new Chief Executive Officer. Ms. Zaslavsky, who has served as the Company’s President and Chief Operating Officer since December 2022, will assume this role

GlobeNewswire 9 months ago

THER

BACK
-12.68%
Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company

Theralink’s patented technology is helping to solve a significant problem in cancer treatment by providing game changing technology that can predict FDA-approved drugs that may be effective in each solid tumor cancer Golden, Colorado, May 23, 2023 (GLOBE NEWSWIRE) -- Theralink Technologies, Inc. (OTC: THER) (“Theralink”) and IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC”), today announced that they have entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) under which Thera

GlobeNewswire 10 months ago

BACK
-12.68%

Performance Overview

Return	BACK	S&P 500
YTD	+40.27%	+5.06%
1-Year	-26.19%	+20.71%
3-Year	-93.85%	+19.73%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

IMAC Holdings, Inc. (BACK)

Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors

Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4

Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute’s Molecular Tumor Board

Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023

IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements

IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split

If You Can Only Buy One Penny Stock, It Better Be One of These 3 Names

IMAC Holdings Announces $4.3 Million Private Placement of Convertible Preferred Stock and Warrants Priced at the Market

IMAC Holdings Annual Meeting of Shareholders Reminder

Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer

Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company

Performance Overview